CorVel Co. (NASDAQ:CRVL) Stock Holdings Increased by Corient Private Wealth LLC

Corient Private Wealth LLC boosted its stake in shares of CorVel Co. (NASDAQ:CRVL) by 292.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 8,904 shares of the business services provider’s stock after acquiring an additional 6,636 shares during the period. Corient Private Wealth LLC’s holdings in CorVel were worth $991,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in CRVL. Royce & Associates LP increased its position in CorVel by 196.0% in the 4th quarter. Royce & Associates LP now owns 3,540 shares of the business services provider’s stock worth $394,000 after purchasing an additional 2,344 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its stake in shares of CorVel by 135.5% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 2,313 shares of the business services provider’s stock valued at $257,000 after buying an additional 1,331 shares in the last quarter. Natixis Advisors LLC acquired a new position in CorVel in the fourth quarter worth approximately $1,606,000. Impact Capital Partners LLC bought a new position in CorVel during the fourth quarter valued at approximately $777,000. Finally, Erste Asset Management GmbH lifted its stake in CorVel by 182.4% in the fourth quarter. Erste Asset Management GmbH now owns 4,800 shares of the business services provider’s stock valued at $546,000 after acquiring an additional 3,100 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

Insider Transactions at CorVel

In related news, CFO Brandon O’brien sold 1,523 shares of CorVel stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total value of $182,089.88. Following the transaction, the chief financial officer now owns 17,142 shares in the company, valued at $2,049,497.52. This trade represents a 8.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jeffrey J. Michael sold 10,477 shares of the company’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $116.45, for a total transaction of $1,220,046.65. Following the sale, the director now owns 568,310 shares of the company’s stock, valued at $66,179,699.50. This trade represents a 1.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,200 shares of company stock worth $3,824,115. 47.57% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a research note on Thursday, March 13th.

CorVel Price Performance

NASDAQ CRVL opened at $111.95 on Friday. CorVel Co. has a fifty-two week low of $76.20 and a fifty-two week high of $128.61. The stock’s 50-day moving average is $112.20 and its two-hundred day moving average is $114.34. The firm has a market cap of $5.75 billion, a P/E ratio of 65.85 and a beta of 1.06.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.